A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell carcinoma (HNSCC); pancreatic ductal adenocarcinoma (PDAC); colorectal cancer (CRC); hepatocellular carcinoma (HCC); adenocarcinoma of esophagus, gastroesophageal junction, and stomach (Ad-Eso/GEJ/gastric); urothelial carcinoma (UC); ovarian cancer (OVC); cervical cancer (CC); biliary tract cancer (BTC); human epidermal growth factor 2 (HER2)-low breast cancer (BC); HER2 immunohistochemistry (IHC) 0 BC; and cutaneous melanoma.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent musi mieć co najmniej jedną zmianę nowotworową, która nie była wcześniej naświetlana i z której można pobrać próbkę do biopsji. Można też użyć próbki z wcześniejszej biopsji, pobranej nie dawniej niż 6 miesięcy temu.
- •Pacjent musi mieć ukończone 18 lat.
- •Na badaniach obrazowych (tomografia komputerowa lub rezonans magnetyczny) musi być widoczna co najmniej jedna mierzalna zmiana nowotworowa.
- •Choroba nowotworowa musiała postępować lub nawrócić po zastosowaniu standardowego leczenia.
- •Ogólny stan zdrowia pacjenta oceniany według skali ECOG musi wynosić 0 lub 1.
- •W przypadku raka endometrium: Pacjent musi mieć potwierdzony rak endometrium lub mięsakobrzegowy, który nawrócił lub postąpił po leczeniu zawierającym platynę i leki wpływające na układ odpornościowy (immunoterapię). Pacjent mógł otrzymać maksymalnie 3 wcześniejsze linie leczenia. Leczenie przedoperacyjne lub uzupełniające może być liczone jako jedna linia, jeśli choroba postąpiła w ciągu 6 miesięcy od jego zakończenia.
- •W przypadku raka głowy i szyi: Pacjent musi mieć potwierdzony nieoperacyjny lub przerzutowy rak płaskonabłonkowy jamy ustnej, gardła środkowego, krtani środkowej lub krtani dolnej, z wyłączeniem nosogardzieli.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 5, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (120)
Valkyrie Clinical Trials
Los Angeles, United States
Los Angeles Cancer Network
Los Angeles, United States
Pih Health Hematology Medical Oncology
Whittier, United States
Orchard Healthcare Research Inc
Skokie, United States
M Health Fairview University of Minnesota Medical Center
Minneapolis, United States
NYU Langone Health
New York, United States
Icahn School of Medicine At Mount Sinai Prime
New York, United States
Clinical Research Alliance, Inc
Westbury, United States
White Plains Hospital
White Plains, United States
Erlanger Health, Inc
Chattanooga, United States
The West Clinic
Germantown, United States
SCRI Oncology Partners
Nashville, United States
Texas Oncology - West Texas
Amarillo, United States
Texas Oncology, P.A.
Dallas, United States
Texas Oncology Gulf Coast
Pearland, United States
Huntsman Cancer Institute, University of Utah
Salt Lake City, United States
Virginia Cancer Specialists
Fairfax, United States
Wenatchee Valley Hospital and Clinics
Wenatchee, United States
Centro de Investigaciones Medicas Mar Del Plata
Mar del Plata, Argentina
Hospital Aleman
Buenos Aires, Argentina
Hospital Sirio Libanes
Caba, Argentina
DIABAID
Buenos Aires, Argentina
Centro Médico Austral
Ciudad Autonoma Buenos Aires, Argentina
Centro de Investigaciones Medicas y Desarrollo LC SRL LC Investigacion
Ciudad Autonoma Buenos Aires, Argentina
Blacktown Hospital
Blacktown, Australia
St Vincent'S Hospital Sydney
Mount Kuring-Gai, Australia
Genesiscare North Shore Oncology
St Leonards, Australia
Princess Alexandra Hospital
Woolloongabba, Australia
St John of God Subiaco Hospital
Subiaco, Australia
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Grand Hospital de Charleroi
Charleroi, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Uz Leuven
Leuven, Belgium
Chu de Liăge
Liège, Belgium
Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil
Hospital São Lucas Da Pucrs
Porto Alegre, Brazil
Cepon - Centro de Pesquisas Oncolăgicas de Santa Catarina
Florianópolis, Brazil
Hospital de Câncer de Barretos - Fundação Pio XII
Barretos, Brazil
Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho
Jaú, Brazil
Biocenter
Concepción, Chile
Centro Del Cancer UC
Santiago, Chile
Clinica Redsalud Vitacura
Santiago, Chile
Ic La Serena Research
La Serena, Chile
James Lind Centro de Investigacion Del Cancer
Temuco, Chile
Centre Georges François Leclerc
Dijon, France
Hopital Saint Andre
Bordeaux, France
Institut Bergonié
Bordeaux, France
Institut Régional Du Cancer de Montpellier
Montpellier, France
CRLCC Eugene Marquis
Rennes, France
Ico - Site René Gauducheau
Saint-Herblain, France
Institut Curie - Site de Paris
Paris, France
Centre Léon Bérard
Lyon, France
GustaveRoussy DptPharmacie
Villejuif, France
Chu Besançon - Hôpital Jean Minjoz
Besançon, France
Institut Claudius Regaud
Toulouse, France
Universitaetsklinikum Heidelberg
Heidelberg, Germany
Slk-Kliniken Heilbronn Gmbh
Heilbronn, Germany
Universitätsklinikum Münster, Medizinische Klinik A
Münster, Germany
Univ der Johannes GutenbergU
Mainz, Germany
Staedtisches Klinikum Dresden Standort Dresden-Friedrichstadt
Dresden, Germany
Universitäres Krebszentrum Leipzig UCCL, UKL AöR
Leipzig, Germany
Vivantes Klinikum Neukoelln
Berlin, Germany
Charită - Campus Charită Mitte
Berlin, Germany
St Vincent'S University Hospital
Dublin, Ireland
Cork University Hospital
Cork, Ireland
Mater Misericordiae University Hospital
Dublin, Ireland
Tallaght University Hospital
Dublin, Ireland
University Hospital Galway
Galway, Ireland
Fondazione Del Piemonte Per L'Oncologia Irccs Candiolo
Candiolo, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda)
Milan, Italy
Istituto Nazionale Tumori Fondazione G. Pascale
Naples, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
Istituto Clinico Humanitas
Rozzano, Italy
Aichi Cancer Center Hospital
Nagoya, Japan
National Cancer Center Hospital East
Kashiwa, Japan
National Hospital Organization Shikoku Cancer Center
Matsuyama, Japan
Kindai University Hospital
Ōsaka-sayama, Japan
Shizuoka Cancer Center
Nagaizumi-cho, Japan
National Cancer Center Hospital
Chuo-ku, Japan
The Cancer Institute Hospital of Jfcr
Koto-ku, Japan
Saitama Cancer Center
Saitama, Japan
Medical Care & Research Sa de Cv
Mérida, Mexico
Centro de Atenciăn E Investigaciăn Clănica En Oncologăa
Mérida, Mexico
Cryptex Investigacion Clinica S.A. de C.V.
México, Mexico
Amsterdam Umc, Locatie Vumc
Amsterdam, Netherlands
Universitair Medisch Centrum Groningen
Groningen, Netherlands
Radboudumc Nijmegen
Nijmegen, Netherlands
Erasmus Medisch Centrum
Rotterdam, Netherlands
Umc Utrecht
Utrecht, Netherlands
SPZOZ Szpital Uniwer w Krakowie
Krakow, Poland
Instytut MSF Sp. z o.o.
Lodz, Poland
MRUK-MED i Spółka z ograniczoną odpowiedzialnością
Rzeszów, Poland
Mazowiecki Szpital Wojewodzki W Siedlcach Sp Z O O
Siedlce, Poland
Aidport Sp Z O.O.
Skorzewo, Poland
Instituto Portuguăs de Oncologia de Lisboa Francisco Gentil, Epe
Lisbon, Portugal
Fundação Champalimaud
Lisbon, Portugal
Centro Hospitalar Universitário de Lisboa Norte
Lisbon, Portugal
Centro Hospitalar Universitario de Santo Antonio
Porto, Portugal
Inst Portude Onco do Porto
Porto, Portugal
Hospital Universitari Vall D'Hebron
Barcelona, Spain
Hospital Clinic de Barcelona
Barcelona, Spain
ICO l'Hospitalet - Hospital Duran i Reynals
Barcelona, Spain
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Hospital Clínico San Carlos
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain
Hospital Universitario Virgen Macarena
Seville, Spain
China Medical University Hospital
Taichung, Taiwan
National Cheng Kung University Hospitalx
Tainan, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Koo Foundation Sun Yat-Sen cancer center
Taipei, Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Medipol Mega University Hospital
Bağcılar, Turkey (Türkiye)
Gulhane Training and Research Hospital
Ankara, Turkey (Türkiye)
Gazi University Medical Faculty
Ankara, Turkey (Türkiye)
Ankara City Hospital
Ankara, Turkey (Türkiye)
Ankara University Cebeci Hospital
Ankara, Turkey (Türkiye)
Izmir Medicalpark Hospital
Izmir, Turkey (Türkiye)
Trial contact
(US) Daiichi Sankyo Contact for Clinical Trial Information
(Asia) Daiichi Sankyo Contact for Clinical Trial Information
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.